Bisphosphonate
Sponsors
Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Queen's University, Pfizer, Amgen, Washington University School of Medicine
Conditions
Arthralgia GeneralizedAtypical Femoral FracturesBisphosphonate TherapyBone LossBreast Cancer FemaleChronic Kidney DiseaseOsteogenesis ImperfectaOsteoporosis
Phase 3
Queen's University Investigation of Calcification in Chronic Kidney Disease
CompletedNCT00687661
Start: 2008-10-31End: 2013-06-30Updated: 2015-09-28
Setrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis Imperfecta
Active, not recruitingNCT05768854
Start: 2023-06-14End: 2027-04-01Updated: 2026-02-25
Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta
RecruitingNCT05972551
Start: 2024-04-22End: 2027-08-25Target: 106Updated: 2026-04-03
Phase 4
Unknown Phase
The preventive effect of bisphosphonate to urolithiasis
RecruitingJPRN-UMIN000002979
Start: 2009-05-01Target: 120Updated: 2025-07-18
Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU)
CompletedNCT01416194
Start: 2011-07-25End: 2019-04-30Updated: 2024-04-22
Denosumab Safety Assessment in Multiple Observational Databases
CompletedNCT02520362
Start: 2010-05-31End: 2023-07-21Updated: 2024-11-04
Exome Sequencing for Atypical Femoral Fractures
CompletedNCT02731040
Start: 2016-04-30End: 2018-03-29Updated: 2018-12-31
Prospective Research for Elderly (≥65 Years Old) Early Breast Cancer Patients
NCT05680194
Start: 2022-04-01End: 2025-12-01Target: 1000Updated: 2023-01-11